Study Estimating Association Between Germline Mutations and PD-L1 Expression in Breast Cancer

Clinical trial NCT03495544 · UNKNOWN

Trial details

NCT number: NCT03495544
Sponsor: Tatarstan Cancer Center
Status: UNKNOWN
Study type: OBSERVATIONAL

Hereditary Breast Cancer

Start date: 2018-01-01
Primary completion: 2019-03-17
Enrollment: 390

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.